Skip to content

Clinical trials

Breast Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Diseases Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20052
20062
20071
20084
20095
20105
20116
20127
20133
20143
20154
20167
20176
201811
201915
202011
202113
20228
202310
20246
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Unknown status33
Recruiting16
Active, not recruiting11
Terminated7
Enrolling by invitation2
Withdrawn2
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Syndax Pharmaceuticals4
Sysmex America, Inc.4
Ma Zhe3
Medipol University3
Novartis Pharmaceuticals3
Hanlim Pharm. Co., Ltd.2
Maastricht University Medical Center2
National Taiwan University Hospital2
Peking Union Medical College Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Diseases146
Breast Neoplasms91
Neoplasms33
Neoplasms by Site22
Neoplasm Metastasis11
Skin Diseases10
Cystic Fibrosis5
Fibroadenoma5
Carcinoma, Non-Small-Cell Lung4
Bronchial Neoplasms3

Trials

Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.